BioIntelliSense
About BioIntelliSense
BioIntelliSense is a leading healthcare AI company dedicated to transforming patient monitoring through its continuous health monitoring and clinical intelligence platform. The company offers a medical-grade Data-as-a-Service (DaaS) solution that seamlessly captures multi-parameter vital signs and physiological biometrics via an effortless patient experience. Their FDA-cleared wearable devices, such as the BioButton® and BioSticker™, are designed for continuous, passive monitoring of critical health indicators including heart rate, respiratory rate, skin temperature, activity levels, body position, and gait analysis. This comprehensive data collection aims to provide a more complete picture of a patient’s health status than intermittent measurements.
The BioIntelliSense ecosystem integrates these wearable sensors with BioHub® gateways, BioMobile™ applications, BioCloud™ data services, and the BioDashboard™ clinical intelligence system. This integrated platform leverages AI-driven analytics to identify statistically meaningful changes from baseline physiology and generate contextual notifications. For physicians, this translates into high-resolution patient trending and actionable insights, facilitating exception-based management and supporting early detection of clinical deterioration. The goal is to enable proactive clinical decision-making, streamline workflows, reduce hospital readmissions, and ultimately improve patient outcomes across various care settings, from acute in-hospital care to post-discharge and chronic remote care management.
By pioneering a new standard of scalable proactive monitoring, BioIntelliSense addresses critical needs in modern healthcare, including alleviating burdens on nursing staff and enhancing the effectiveness of virtual care programs. Their mission is to make physiological monitoring accessible to every patient, leveraging advanced technology to deliver better, safer, and more cost-effective care by moving from reactive to proactive health management.
Focus Areas
Business Intelligence
| Key Investors | Chimera, 7wire Technology Partners, Mary Tolan of Chicago Pacific Founders, James Murren, Pendrell Corporation, Royal Philips, Fresenius Medical Care North America, TripleTree Holdings, UCHealth, CU Healthcare Innovation Fund, Confluent, Dexcom Ventures, TLG Capital Management |
| Partnerships | Medtronic, Hicuity Health, Renown Health, iRhythm, Philips, Houston Methodist, Medically Home |
| Acquisitions | AlertWatch |
| Technology | Data-as-a-Service (DaaS) platform, BioButton® multiparameter wearables, BioHub™ gateways (Wi-Fi, cellular, 5G), BioMobile™ downloadable applications, BioCloud™ data services, BioDashboard™ clinical intelligence system, AI-driven analytics, cloud-native (AWS), Rhapsody (for integration) |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
For physicians, BioIntelliSense stands out by offering **earlier detection of patient deterioration** (averaging 14.8 hours in advance), which can significantly reduce unplanned ICU admissions, rapid response team activations, and overall length of hospital stay. The **automation of high-frequency vital sign collection** frees up nursing staff, allowing them to focus on patients who need care most, and contributes to reduced burnout. The **BioDashboard provides actionable, personalized insights and alerts** through an exception management approach, minimizing alert fatigue while ensuring critical changes are highlighted. The **scalable monitoring capabilities** seamlessly extend from in-hospital to home, supporting virtual care models, chronic disease management, and post-discharge care. Furthermore, the **RPM reimbursable nature** of their FDA-cleared devices offers clear financial benefits for practices. The discreet and effortless patient experience of the wearables also contributes to higher patient satisfaction.
BioIntelliSense's BioButton and BioDashboard System is a sophisticated cloud-based platform designed for **robust third-party and EMR system integration and data exchange capabilities**. They have demonstrated successful integration with Electronic Medical Record systems like Epic to streamline clinical workflows. The company also forms strategic partnerships with virtual care providers, such as Hicuity Health and VeeMed, to offer fully managed, end-to-end continuous patient monitoring services, addressing staffing and infrastructure challenges for health systems.
What the Web Says
BioIntelliSense offers continuous health monitoring and clinical intelligence solutions through wearable devices like the BioSticker and BioButton. These devices collect physiological data such as heart rate, respiratory rate, skin temperature, and activity levels for up to 30 days, aiming to provide early detection of patient deterioration and improve patient outcomes. The company's technology is designed to be user-friendly for patients and to streamline workflows for healthcare providers.
Overall: PositiveStrengths
- Continuous and accurate monitoring of vital signs and physiological biometrics.
- Early detection of patient deterioration, with notifications often preceding events.
- Reduces the time nurses spend on manual vital sign collection, allowing for more patient interaction.
- Can lead to a shorter average length of stay for patients in medical-surgical units.
- Effortless patient experience with non-invasive, easy-to-wear devices.
- HIPAA compliant and aligns with security standards.
Limitations
- Concerns about data not being accurate have been raised.
- Proper training is required for doctors, nurses, and IT staff to use the system effectively.
- Some studies on the BioButton device for physical activity monitoring in children noted missing data due to discomfort or visibility.
- The original BioButton was a single-use device, though a rechargeable version is now available.
- Limited information available on employee reviews from major platforms like Glassdoor or Capterra, making it difficult to assess overall company culture or employer sentiment.
Based on reviews from: Health Technology Review - DoH, Zippia, Early Detection of 73% of Clinical Deterioration Events Using AWS with BioIntelliSense, Evidence - BioIntelliSense, Validation of the BioIntelliSense BioButtonu00ae device for physical activity monitoring in children and future application as a physical health outcome for critically Ill children - PMC, BioIntelliSense BioButtonu2122 Named Best New Monitoring Solution by MedTech Breakthrough Awards - PR Newswire, Tracking not just data, but individual symptoms, like vomiting: BioIntelliSense exits stealth with FDA-cleared wearable | Fierce Biotech, BioIntelliSense 2026 Company Profile: Valuation, Funding & Investors | PitchBook, BioIntellisense Careers and Employment | Indeed.com, BioIntelliSense debuts rechargeable version of its wearable vital sign tracker, How a wearable is optimizing patient monitoring at Houston Methodist - Becker's Hospital Review | Healthcare News & Analysis
Last updated: 2026-07-21
Videos
News, demos, and interviews about BioIntelliSense.
Videos load interactively. If none appear, search YouTube for BioIntelliSense →
Press & Coverage
Frequently Asked Questions
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]